<DOC>
	<DOC>NCT01690949</DOC>
	<brief_summary>This trial in healthy subjects will assess PUR118's effect on attenuating ozone induced airway inflammation. This trial will establish the tolerability of PUR118 in healthy normal volunteers.</brief_summary>
	<brief_title>Evaluation of the Effect of PUR118 on Ozone Induced Airway Inflammation in Healthy Normal Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<criteria>Healthy males or non pregnant, non lactating healthy females age 1850 years; Must be able to produce acceptable sputum sample by induction; Must respond to ozone inhalation with a &gt; 10% increase in the absolute percentage of sputum neutrophils and the total neutrophils (neutrophils/gram sputum) must increase by at least 50% from the sputum neutrophil count at screening; Volunteer is a nonsmoker or exsmoker of at least 12 months' duration prior to screening with a history of less than 1 pack per year. Volunteers receiving chronic medication other than oral contraceptives; Screening forced expiratory volume FEV1 is &lt; 80% of the predicted value for their age, gender, height and race and/or their FEV1/FVC ration is below 70%; Volunteers with significant occupational exposure to respiratory irritants or toxins Upper respiratory tract infection within 30 days of the first study day, or lower respiratory tract infection within the last 3 months; Volunteers taking any medication that may affect the respiratory tract within 30 days of the first study day; Volunteers with a history of asthma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>inflammation</keyword>
	<keyword>COPD</keyword>
	<keyword>respiratory disease</keyword>
	<keyword>healthy volunteers</keyword>
</DOC>